Neratinib in the Early-Stage/Extended Adjuvant Breast Cancer Patient: Q&A

被引：0
|
作者：
O'Shaughnessy, Joyce A.
O'Regan, Ruth
Isaacs, Claudine
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [1] Modeling longer-term efficacy of neratinib in the extended adjuvant setting for early-stage breast cancer.
    Danese, Mark D.
    Halperin, Marc
    Lalla, Deepa
    Yao, Bin
    Crown, John
    Doan, Quan V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Best Use of Neratinib in Patients With Early-Stage Breast Cancer
    O'Shaughnessy, Joyce A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 11 - 16
  • [3] Neratinib in Early-Stage Breast Cancer: Clinical Trial Data
    O'Regan, Ruth
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 7 - 10
  • [4] US Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
    Singh, Harpreet
    Walker, Amanda J.
    Amiri-Kordestani, Laleh
    Cheng, Joyce
    Tang, Shenghui
    Balcazar, Pamela
    Barnett-Ringgold, Kimberly
    Palmby, Todd R.
    Coo, Xianhua
    Zheng, Nan
    Liu, Qi
    Yu, Jingyu
    Pierce, William F.
    Daniels, Selena R.
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kluetz, Paul G.
    Blumenthal, Gideon M.
    Beaver, Julia A.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 3486 - 3491
  • [5] Patient preferences for adjuvant treatment of early-stage breast cancer.
    Fama, T
    Wood, M
    Muss, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 61S - 61S
  • [6] Extended adjuvant therapy for early-stage breast cancer: Are there markers for its use?
    Klar, Natalie
    Brufsky, Adam
    BREAST JOURNAL, 2019, 25 (01): : 7 - 8
  • [7] Adjuvant chemotherapy for early-stage breast cancer
    McArthur, Heather L.
    Hudis, Clifford A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 207 - +
  • [8] Adjuvant bisphosphonates for early-stage breast cancer
    Brufsky, Adam
    LANCET ONCOLOGY, 2011, 12 (07): : 610 - 611
  • [9] Neratinib in Early-Stage HER2-Positive Breast Cancer
    Cherian, Mathew A.
    Ma, Cynthia X.
    BREAST DISEASES, 2015, 26 (04): : 285 - 287
  • [10] Biomarkers for Early-Stage Breast Cancer: Clinical Utility for Extended Adjuvant Treatment Decisions
    Sgroi, Dennis C.
    Brufsky, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3941 - +
12345